These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 10723138)
1. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers. Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138 [TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors. Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351 [TBL] [Abstract][Full Text] [Related]
3. Mapping of chromosome 3p deletions in human epithelial ovarian tumors. Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467 [TBL] [Abstract][Full Text] [Related]
4. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2. Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959 [TBL] [Abstract][Full Text] [Related]
7. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895 [TBL] [Abstract][Full Text] [Related]
8. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522 [TBL] [Abstract][Full Text] [Related]
10. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516 [TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer is a heterogeneous disease. Wang V; Li C; Lin M; Welch W; Bell D; Wong YF; Berkowitz R; Mok SC; Bandera CA Cancer Genet Cytogenet; 2005 Sep; 161(2):170-3. PubMed ID: 16102589 [TBL] [Abstract][Full Text] [Related]
12. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer. Huang H; Reed CP; Mordi A; Lomberk G; Wang L; Shridhar V; Hartmann L; Jenkins R; Smith DI Genes Chromosomes Cancer; 1999 Jan; 24(1):48-55. PubMed ID: 9892108 [TBL] [Abstract][Full Text] [Related]
13. A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors. Kalikin LM; Frank TS; Svoboda-Newman SM; Wetzel JC; Cooney KA; Petty EM Oncogene; 1997 Apr; 14(16):1991-4. PubMed ID: 9150366 [TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340 [TBL] [Abstract][Full Text] [Related]
15. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612 [TBL] [Abstract][Full Text] [Related]
16. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma]. Yang YQ; Li JC Ai Zheng; 2006 Jun; 25(6):713-7. PubMed ID: 16764766 [TBL] [Abstract][Full Text] [Related]
17. Human epithelial ovarian cancer allelotype. Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830 [TBL] [Abstract][Full Text] [Related]
19. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma. Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483 [TBL] [Abstract][Full Text] [Related]
20. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene. Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]